Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Seoul virus glycoprotein Gc is a critical structural component of the Seoul virus (SEOV) envelope, a member of the Hantaviridae family [4, 9]. It is a Class II viral fusion protein that forms heterodimeric spikes with the Gn protein on the virion surface [5, 10]. Gc is primarily responsible for mediating the fusion of the viral envelope with the host cell's endosomal membrane in a pH-dependent manner, facilitating the release of the viral genome into the cytoplasm [5, 10, 29]. As a major surface antigen, Gc is a primary target for the host's neutralizing antibody response and is a focal point for the development of vaccines and antiviral therapeutics [22, 26, 30]. SEOV is a zoonotic pathogen transmitted by rats (Rattus norvegicus) and causes Hemorrhagic Fever with Renal Syndrome (HFRS) in humans, characterized by fever, thrombocytopenia, and acute kidney injury [4, 13, 15]. Therapeutic strategies targeting Gc include the use of neutralizing monoclonal antibodies, entry-inhibiting small molecules like cepharanthine, and various vaccine platforms such as inactivated virus, DNA, and recombinant protein subunits [3, 22, 32, 34].
Gc-targeted agents primarily act by inhibiting the pH-dependent membrane fusion process, neutralizing the virus by blocking receptor attachment, or preventing the conformational changes required for viral entry into the host cell [5, 26, 34].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Seoul virus glycoprotein Gc (Gc).